Charles River loses $12m National Cancer Institute contract
The US National Cancer Institute (NCI) recently terminated a contract with Charles River Laboratories (CRL) to supply rodents for cancer research.
The US National Cancer Institute (NCI) recently terminated a contract with Charles River Laboratories (CRL) to supply rodents for cancer research.
The Association of Clinical Research Organizations (ACRO) offered a number of recommendations to the US House Energy and Commerce Committee’s “21st Century Cures” initiative last week as part of an effort to keep the US research industry competitive...